Platelet-derived products (PDPs) have gained popularity, mainly due to their high concentrations of bioactive molecules such as growth factors and cytokines, which play important roles in tissue healing and regeneration. PDPs are obtained through minimally invasive procedures and their therapeutic effect has been widely recognized. In veterinary medicine, however, the lack of standard protocols to generate PDPs is a major hurdle for assessing the clinical relevance of PDP-based therapies and for their widespread usage. The aim of this review is to analyze the technical and scientific specificities of PDPs in terms of preparation methodologies, classification categorization, nomenclature, and biological proprieties to advance their future biotechnological potential in veterinary contexts.

血小板衍生产品 (PDP) 受到欢迎，主要是因为它们含有高浓度的生物活性分子，如生长因子和细胞因子，它们在组织愈合和再生中起着重要作用。PDPs是通过微创手术获得的，其治疗效果已得到广泛认可。然而，在兽医学中，缺乏生成 PDP 的标准协议是评估基于 PDP 的疗法的临床相关性及其广泛使用的主要障碍。本综述的目的是分析 PDP 在制备方法、分类分类、命名和生物学特性方面的技术和科学特性，以提高它们在兽医领域的未来生物技术潜力。